New User
Forgot Password ?
Thank you for your interest in this position. We regret the job is no more available.
Please continue to search for opportunities
Job Description
Job: AstraZeneca China Global MBA Program
Finance - Accounting, Insurance, Other, Marketing & Communications, Operations, Production & Supply Chain role
Full Time Job
Posted on: October 29, 2019
Deadline: December 28, 2019
Locations: China
Job Description:
(primary responsibilities,
reporting structure,
career path...)
We provide below functions to students who would purse in
• Sales &Marketing
• Strategy &PMO (Project Management office)
• Commercial Strategy and Excellence
• Digital &Commercial Innovation
• Business Development
• Enabling functions: HR, Finance
Job qualifications and experience, academic degrees, personal traits...
Our expectations of MBA candidates:
• Graduate student completing a full-time MBA program between August 2019 and August 2020.
• A minimum of 3 years work experience is required. People management role is a plus
• Experience with sales and marketing role and/or in healthcare industry is preferred but not mandatory
• Fluency in English and Mandarin
• Chinese citizens or eligible to acquire Chinese work permit
• Clear interest in pharmaceutical industry and willing to take operational roles
• Leadership capabilities demonstrated through extracurricular activities, employment and/or internship experiences
• Proven record of high performance
• Strong commercial acumen and analytical skills
Name: Jane Qiang

Industry Consulting/Healthcare
Company description

'AstraZeneca entered China in 1993 and its China headquarters are located in Shanghai. With approximately 13,000 employees throughout the country, the company achieved sales of nearly USD 3.8 billion in 2018. AstraZeneca has invested over USD 1 billion in China, building R&D centre in Shanghai and manufacturing sites in Wuxi and Taizhou, Jiangsu, as well as the China Distribution Center in Wuxi. AstraZeneca China Commercial Innovation Center and Healthcare Internet of Things Innovation Center was established in Wuxi in 2017. In 2019, AstraZeneca announced to co-build the Wuxi International Life Science Innovation Park with the Wuxi municipal government and Wuxi Hi-tech District. AstraZeneca has introduced about 30 innovative medicines covering respiratory, cardiovascular, metabolic, oncology, gastrointestinal and renal diseases in China.
We are committed to delivering growth and TA leadership, accelerating innovative science and being a great place to work, so as to drive business growth in China and realize sustainable development, fulfilling our grand mission of “becoming China’s most trusted healthcare partner by bringing forth innovative solutions to improve the lives of Chinese patients”. '